MARKET OVERVIEW
Pharmaceutical is a broad segment that consolidates a group of chemicals classified based on their pharmacological effect and therapeutic use. For instance, Alkaloids were the first pure pharmaceuticals derived from plants; they include quinine, nicotine, cocaine, atropine, and morphine. Similarly, some drugs are made of animal origin, which includes glandular extracts containing hormones. Drugs or medicines from animal origins are biological, biosimilar, and vaccines. These pharmaceutical products diagnose, treat, and prevent chronic diseases like cancer, diabetes, and genetic disorders.
MARKET SCOPE
The "Global Pharmaceutical Analysis to 2028" is a specialized and in-depth examination of the healthcare industry, with a particular emphasis on global market trend analysis. The purpose of this report is to provide an overview of the pharmaceutical market, as well as detailed market segmentation based on product. Additionally, the report offers key statistics on the market status of the leading pharmaceutical market players, as well as key market trends and opportunities.
MARKET SEGMENTATION
- Based on product, the market is segregated into branded drugs, generics, biological and biosimilar products, vaccines, and others.
MARKET DYNAMICS
Drivers-
- Growing prevalence of chronic and acute diseases
- Rising research and developments in the pharmaceutical industry
- Increasing production of pharmaceutical products
Restraint-
- Stringent regulations from regulatory bodies and increasing product recall
REGIONAL FRAMEWORK
The report offers a comprehensive overview of the industry, including both qualitative and quantitative data. It provides a global market overview and forecast based on various segments. It also provides market size and forecast estimates of country-wise statistics from 2022 to 2028. Each region's pharmaceutical market is further subdivided by respective countries and segments.
The report analyses market factors affecting both the demand and supply sides, as well as market dynamics affecting the market during the forecast period, such as drivers, restraints, opportunities, and future trends. The report also includes a comprehensive PEST analysis for Brazil after assessing the political, economic, social, and technological factors influencing the pharmaceutical market in these regions.
Impact of COVID-19 on Pharmaceutical Market
The ongoing COVID-19 pandemic has imposed a heavy toll on human life, health care, the global economy, and almost every aspect of human life. The COVID-19 pandemic has impacted all drug development phases and forced many drug development companies and clinical research organizations to put at least some of their clinical studies on hold. Despite these devastating effects, COVID-19 has also mobilized and united many drug discovery and development elements in seeking therapies to address this most pressing public health emergency. The COVID-19 pandemic also has impacted the supply of active materials and ingredients and the import and export of pharmaceuticals.
MARKET PLAYERS
The report covers key developments in the pharmaceutical market with a focus on two main strategies such as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies that include new product launches, product approvals by authorized bodies, and others such as patents and events. Inorganic growth strategies activities normally include strategic acquisitions and, partnerships & collaborations between the companies. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the pharmaceutical market are anticipated to have lucrative growth opportunities with the rising demand for pharmaceuticals in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the pharmaceutical market. Also, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Amgen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Celgene Corporation
- Shire plc
- Zoetis Inc.
The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.